Therapeutic strategies in gastric cancer.

Therapeutic strategies in gastric cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Saved in:

Bibliographic Details
Main Authors:	Wong, J.E., Ito, Y., Correa, P., Peeters, K.C., van, de Velde C.J., Sasako, M., Macdonald, J.
Other Authors:	MEDICINE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/117931
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Unmet needs and challenges in gastric cancer: The way forward
by: Lordick, F., et al.
Published: (2014)

Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
by: Yan, B., et al.
Published: (2014)

Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
by: Yeo, W., et al.
Published: (2011)

Prognosticating gastric cancer
by: Yeoh, K.G., et al.
Published: (2011)

Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
by: McCormack, W., et al.
Published: (2014)

Endoscopic Screening for Gastric Cancer
by: Dan, Y.Y., et al.
Published: (2011)

Detection of telomerase activity in gastric lavage fluid: A novel method to detect gastric cancer
by: Ching-Ho, Wong S., et al.
Published: (2011)

The current status of laparoscopic resection for gastric cancer
by: So, J.B.Y., et al.
Published: (2016)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
by: Subhash, V.V, et al.
Published: (2020)

Mining the gastric cancer secretome: Identification of GRN as a potential diagnostic marker for early gastric cancer
by: Loei, H., et al.
Published: (2014)

Screening for gastric cancer in Asia: current evidence and practice
by: Leung, W.K., et al.
Published: (2016)

Oncogenic pathway combinations predict clinical prognosis in gastric cancer
by: Ooi, C.H., et al.
Published: (2011)

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
by: Palanisamy, N., et al.
Published: (2014)

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
by: Deng, N., et al.
Published: (2014)

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization
by: Ito, K., et al.
Published: (2012)

Clinical and pathological features of early gastric cancer in Singapore
by: So, J.B.-Y., et al.
Published: (2014)

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization
by: Ito, K., et al.
Published: (2011)

Therapeutic and prophylactic effect of Andrographis paniculata on aspirin-induced gastric ulcer
by: Saboriendo, Sheryl V., et al.
Published: (2017)

The Biology of Gastric Cancers
Published: (2017)

CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer
by: Liu, Q., et al.
Published: (2011)

CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer
by: Liu, Q., et al.
Published: (2012)

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2011)

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2012)

Palliation of advanced gastric cancer by laparoscopic gastrojejunostomy.
by: Kum, C.K., et al.
Published: (2011)

Endoscopic ultrasonography for gastric cancer: Does it influence treatment?
by: Ganpathi, I.S., et al.
Published: (2016)

Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells
by: Ju, X., et al.
Published: (2016)

Silver nanoparticles in cancer: Therapeutic efficacy and toxicity
by: Ong, C., et al.
Published: (2014)

Silver nanoparticles in cancer: Therapeutic efficacy and toxicity
by: Ong, C., et al.
Published: (2014)

Whole-genome reconstruction and mutational signatures in gastric cancer
by: Nagarajan N., et al.
Published: (2018)

RUNX3 expression correlates with chief cell differentiation in human gastric cancers
by: Ogasawara, N., et al.
Published: (2011)

Palliation of malignant gastric outlet obstruction caused by gastric cancer with self-expandable metal stents
by: Wai, C.T., et al.
Published: (2016)

Palliation of malignant gastric outlet obstruction caused by gastric cancer with self-expandable metal stents
by: Wai, C.T., et al.
Published: (2014)

Genomic and proteomic advances in gastric cancer
by: Boussioutas, A., et al.
Published: (2016)

Methods For Detection Of Gastric Cancer
by: LIM YOON PIN, et al.
Published: (2012)

ROLE OF MICRORNAS IN GASTRIC CANCER
by: NG HONG KIAT
Published: (2018)

Targeted therapy to gastric cancer
by: Hou, Qian.
Published: (2009)

Induction of gastric cancer by successive oncogenic activation in the corpus.
by: Douchi, Daisuke, et al.
Published: (2021)

ITIH3 Is a potential biomarker for early detection of gastric cancer
by: Chong, P.K., et al.
Published: (2011)

Protein profiling of human gastric fluid and gastric cancer biomarker discovery.
by: LAI LIYUN
Published: (2014)

Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer
by: Zhao, J, et al.
Published: (2020)